CLINICAL SUPPLY MANAGEMENT ARTICLES
Clinical Trial Supply Failures Start Before First Patient In
Many trial supply disruptions are set in motion years before enrollment begins. Hedley Rees explains how early decisions shape risk, forecasting, inventory, and execution.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?
-
Recently, there has been a lot of messaging around agility in Randomization and Trial Supply Management (RTSM) or as some refer to it, Interactive Response Technology (IRT). Is “agile” becoming the new “innovative”? Find out more in this white paper.
-
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
Do pharma companies underestimate supply chain challenges? Much can go wrong when sending a therapy from A to B, but the right collaborations can mitigate risk.
-
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
-
Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.